Skip to main content
SpringerLink
Log in

When Surgeons and Endoscopists Are Possible Opponents

  • Chapter
  • First Online:
Bariatric Therapy

  • 245 Accesses

Abstract

If endoscopists and surgeons’ interests may collide against each other occasionally, most of the time bariatric patients will find and also require a sound collaboration, to define the best strategy. Class I obesity (BMI 30–35 kg/m2) seems the most important field where endoscopy and bariatric surgery compete, a competition that is intensified by national guidelines and insurance requirements. Currently, surgical techniques like gastric plication and bypass-malabsorption have an endoscopic counterpart that is being developed, while GORD is an intricate issue. Recommendations could be instrumental soon.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACE:

Articulating circular endoscopic

ARMS:

Anti-reflux mucosectomy

ASGE:

American Society for Gastrointestinal Endoscopy

ASMBS:

American Society of Metabolic Bariatric Surgery

BMI:

Body mass index

DJBL:

Duodenojejunal bypass liner

DJBS:

Duodenojejunal bypass sleeve

EBT:

Endoscopic bariatric therapy

EMA:

European Medicines Agency

ESG:

Endoscopic sleeve gastroplasty

EWL:

Excess weight loss

FDA:

Food and Drug Administration

FU:

Follow-up

GI:

Gastrointestinal

GLP-1:

Glucagon-like peptide-1

GORD:

Gastro-oesophageal reflux disease

IFSO:

International Federation for the Surgery of Obesity

LAGB:

Laparoscopic adjustable gastric banding

LGCP:

Laparoscopic greater curve plication

PIVI:

Preservation and Incorporation of Valuable endoscopic Innovations

POSE:

Primary Obesity Surgery Endolumenal

PPI:

Proton pump inhibitor

PYY:

Peptide YY

RCT:

Randomised clinical trial

RYGB:

Roux-en-Y gastric bypass

SG:

Sleeve gastrectomy

T2DM:

Type 2 diabetes mellitus

TBWL:

Total body weight loss

TERIS:

Transoral restrictive implant system

References

  1. Verlaan T, Paulus GF, Mathus-Vliegen EMH, Veldhuyzen EAML, Conchillo JM, Bouvy ND, et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity. Gastrointest Endosc. 2015;81:312–20.

    Article  Google Scholar 

  2. O’Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.

    Article  Google Scholar 

  3. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  CAS  Google Scholar 

  4. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.

    Article  Google Scholar 

  5. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  CAS  Google Scholar 

  6. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240–9.

    Article  CAS  Google Scholar 

  7. Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L. Bariatric surgery in class I obesity. A position statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2014;24(4):487–519.

    Article  Google Scholar 

  8. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 3–5 June 1997. Report 1998 No.: WHO/NUT/NCD/98.1.

    Google Scholar 

  9. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical Guidelines on the Identification. Evaluation, and treatment of overweight and obesity in adults- the evidence report. Obes Res. 1998;6(Suppl. 2):1S–209S.

    Google Scholar 

  10. National Institute for Health and Care Excellence. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. London, United Kingdom: National Institute for Health and Care Excellence; 2006. www.NICE.org.uk

    Google Scholar 

  11. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63:2985–3023.

    Article  Google Scholar 

  12. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.

    Article  Google Scholar 

  13. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342–62.

    Article  CAS  Google Scholar 

  14. Talebpour M, Amoli BS. Laparoscopic total gastric vertical plication in morbid obesity. J Laparoendosc Adv Surg Tech A. 2007;17:793–8.

    Article  Google Scholar 

  15. Kirk RM. An experimental trial of gastric plication as a means of weight reduction in the rat. Br J Surg. 1969;56:930–3.

    Article  CAS  Google Scholar 

  16. Brethauer SA, Harris JL, Kroh M, Schauer P. Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis. 2010;7(1):15–22.

    Article  Google Scholar 

  17. Fried M, Dolezavola K, Buchwald JN, McGlennon TW, Stramkova P, Ribaric G, et al. Laparoscopic greater curve plication (LGCP) for treatment of morbid obesity in a series of 224 patients. Obes Surg. 2012;22(8):1298–307.

    Article  CAS  Google Scholar 

  18. Zerrweck C, Rodríguez JG, Aramburo E, Viscara R, Rodriguez JL, Solorzano A, et al. Revisional surgery following laparoscopic gastric plication. Obes Surg. 2017;27(1):38–43.

    Article  Google Scholar 

  19. Ye Q, Chen Y, Zhan X, Wang Y, Zhu J. Comparison of laparoscopic sleeve gastrectomy and laparoscopic greater curvature plication regarding efficacy and safety: a meta-analysis. Obes Surg. 2017;27:1358–64.

    Article  Google Scholar 

  20. Shen D, Ye H, Wang Y, Ji Y, Zhan X, Zhu J, et al. Comparison of short-term outcomes between laparoscopic greater curvature plication and laparoscopic sleeve gastrectomy. Surg Endosc. 2013;27(8):2768–74.

    Article  Google Scholar 

  21. Chouillard E, Schoucair N, Alsabah S, Alkandari B, Montana L, Dejonghe B, et al. Laparoscopic Gastric Plication (LGP) as an alternative to Laparoscopic Sleeve Gastrectomy (LSG) in patients with morbid obesity: A Preliminary, Short-Term, Case-Control Study. Obes Surg. 2016;26(6):1167–72.

    Article  Google Scholar 

  22. Sharma S, Narwaria M, Cottam DR, Cottam S. Randomized double-blinded trial of laparoscopic gastric imbrication v laparoscopic sleeve gastrectomy at a single Indian institution. Obes Surg. 2015 May;25(5):800–4.

    Article  Google Scholar 

  23. Abdelbaki TN, Sharaan M, Abdel-Baki NA, Katri K. Laparoscopic gastric greater curvature plication versus laparoscopic sleeve gastrectomy: early outcome in 140 patients. Surg Obes Relat Dis. 2014;10(6):1141–6.

    Article  Google Scholar 

  24. Grubnik VV, Ospanov OB, Namaeva KA, Medvedev OV, Kresyun MS. Randomized controlled trial comparing laparoscopic greater curvature plication versus laparoscopic sleeve gastrectomy. Surg Endosc. 2016;30(6):2186–91.

    Article  CAS  Google Scholar 

  25. Kumar N. Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeve, intragastric balloons, and aspiration. World J Endosc. 2015;7(9):847–59.

    CAS  Google Scholar 

  26. Horgan S, Jacobsen G, Weiss GD, Oldham JS Jr, Denk PM, Borao F, et al. Incisionless revision of post-roux-en-Y bypass stomal and pouch dilatation: multicenter registry results. Surg Obes Relat Dis. 2010;6(3):290–5.

    Article  Google Scholar 

  27. Espinos JC, Turro R, Mata A, Cruz M, da Costa M, Villa V, et al. Early experience with the incisionless operating platformTM (IOP) for the treatment of obesity. Obes Surg. 2013;23(9):1375–83.

    Article  CAS  Google Scholar 

  28. Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castaño I, et al. Endoscopic Sleeve Gastroplasty for obesity: a Multicenter Study of 248 patients with 24 months follow-up. Obes Surg. 2017;27(10):2649–55.

    Article  Google Scholar 

  29. Rubino F, Zizzari P, Tomasetto C, Bluet-Pajot MT, Forgione A, Vix M, et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology. 2005;146(4):1745–51.

    Article  CAS  Google Scholar 

  30. Patel SR, Hakim D, Mason J, Hakim N. The duodenal-jejunal bypass sleeve (EndoBarrier gastrointestinal liner) for weight loss and treatment of type 2 diabetes. Surg Obes Relat Dis. 2013;9:482–4.

    Article  Google Scholar 

  31. Zechmeister-Koss I, Huic M, Fischer S. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review. Obes Surg. 2014;24:310–23.

    Article  Google Scholar 

  32. Rohde U, Hedbäck N, Gluud LL, Visboll T, Knop FK. Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2016;18:300–5.

    Article  CAS  Google Scholar 

  33. de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23:1354–60.

    Article  Google Scholar 

  34. Vilarrasa N, de Gordejuela AG, Casajoana A, Duran X, Toro S, Espinet E, et al. Endobarrier in Grade I obese patients with long-standing Type 2 diabetes: role of gastrointestinal hormones in glucose metabolism. Obes Surg. 2017;27(3):569–77.

    Article  Google Scholar 

  35. van der Wielen N, Paulus G, van Avesaat M, Masclee A, Meijerink J, Bouvy N. Effect of endoscopic gastroplication on the genome-wide transcriptome in the upper gastrointestinal tract. Obes Surg. 2017;27:740–8.

    Article  Google Scholar 

  36. Rajagopalan H, Cherrington AD, Thompson CC, Kaplan LM, Rubino F, Mingrone G, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diab Care. 2016;39:2254–61.

    Article  CAS  Google Scholar 

  37. Crawford C, Gibbens K, Lomelin D, Krause C, Simorov A, Oleynikov D. Sleeve gastrectomy and anti-reflux procedures. Surg Endosc. 2017;31:1012–21.

    Article  Google Scholar 

  38. Triadafilopoulos G. Endoscopic options for gastroesophageal reflux: where are we now and what does the future hold? Curr Gastroenterol Rep. 2016;18:47.

    Article  Google Scholar 

  39. White B, Jeansonne LO, Cook M, Chavarriaga LF, Goldenberg EA, Davis SS, et al. Use of endoluminal antireflux therapies for obese patients with GERD. Obes Surg. 2009;19(6):783–7.

    Article  Google Scholar 

  40. Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1058–67.

    Article  Google Scholar 

  41. Johnson DA, Ganz R, Aisenberg J, Cohen LB, Deviere J, Foley TR, et al. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol. 2003;98(9):1921–30.

    Article  CAS  Google Scholar 

  42. Pleskow D, Rothstein R, Lo S, Hawes R, Kozarek R, Haber G, et al. Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial. Gastrointest Endosc. 2004;59(2):163–71.

    Article  Google Scholar 

  43. Leitman IM, Virk CS, Avgerinos DV, Patel R, Lavarias V, Surick B, et al. Early results of trans-oral endoscopic plication and revision of the gastric pouch and stoma following Roux-en-Y gastric bypass surgery. JSLS. 2010;14:217–20.

    Article  Google Scholar 

  44. Dargent J, Mion F, Costil V, Pontette F, Ecochard D, Mion M. Multicenter randomized study of obesity treatment with minimally invasive injection of hyaluronic acid versus and combined with intragastric balloon. Obes Surg. 2015;25(10):1842–7.

    Article  Google Scholar 

  45. Dargent J, Vilallonga R, Katz L, Portenier D, Wilson E, Escalona A, et al. IFSO position statement on new technologies in bariatric surgery. Obes Surg. 2017;27(9):2456–9.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. E. M. H. Mathus-Vliegen and J. Dargent contributed equally to this work.

Authors and Affiliations

  1. Amsterdam UMC (University Medical Centres), Amsterdam, The Netherlands

    Elisabeth M. H. Mathus-Vliegen

  2. Polyclinique Lyon Nord, Lyon, France

    Jérôme Dargent

Authors
  1. Elisabeth M. H. Mathus-Vliegen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jérôme Dargent
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mathus-Vliegen, E.M.H., Dargent, J. (2018). When Surgeons and Endoscopists Are Possible Opponents. In: Bariatric Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-90074-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90074-2_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90073-5

  • Online ISBN: 978-3-319-90074-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation